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I n this issue of JGIM, Alford and colleagues report on a phenomenon that is already of major significance to generalists and their patients (and only likely to become increasingly so): the co-occurrence of chronic pain and substance use, misuse and substance use disorders. 1 This work appropriately sounds the alarm that our treatment strategies, and, upstream, education and training of current and future generalists, needs to be responsive to the current reality and ongoing trend. It also advances methodological work in exploring one of the hypothesized direct pathways between pain and substance use: self-medication.
Alford et al. found that among nearly 600 adult patients in an urban primary care setting who screened positive for any illicit drug use or prescription drug misuse, chronic pain was reported by a remarkable 87 %, with 13 % rating that pain as mild, 24 % moderate and 50 % severe. Pain-related dysfunction, a more salient measure for clinical action, was reported by an even more remarkable 74 % with 15 % mild, 23 % moderate, and 36 % severe. These data are on the high end of the range of previously reported related findings, 2, 3 likely in part explained by differences in population studied and outcome ascertainment. However, another probable contributory explanation is that with soaring opioid prescribing in the past 20 years 4 and ageing of the population, the prevalence of co-occurring chronic pain and opioid misuse (present in a significant proportion of their sample) has simply increased.
Half who used illicit drugs reported using them to treat pain. Over 80 % with prescription drug misuse did so to treat pain. One potential source of lack of specificity (and thus false positivity) in this metric was the use of Bpain or discomfortî n the question stem. It is conceivable, but likely rare, that respondents might have meant anxiety or discomforting distress as the target of self-medication rather than pain per se. Nonetheless, undoubtedly, these data further argue for high quality pain assessment and treatment as part and parcel with primary care's management of harmful substance use.
